.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Chinese Patent Office
AstraZeneca
Daiichi Sankyo
Merck
Covington
Cipla
Accenture
Julphar
Harvard Business School

Generated: December 15, 2017

DrugPatentWatch Database Preview

Shire Orphan Therap Company Profile

« Back to Dashboard

What is the competitive landscape for SHIRE ORPHAN THERAP, and when can generic versions of SHIRE ORPHAN THERAP drugs launch?

SHIRE ORPHAN THERAP has one approved drug.

There is one US patent protecting SHIRE ORPHAN THERAP drugs on SHIRE ORPHAN THERAP drugs in the past three years.

There are one hundred and twelve patent family members on SHIRE ORPHAN THERAP drugs in thirty-three countries and six supplementary protection certificates in five countries.

Summary for Shire Orphan Therap

International Patents:112
US Patents:1
Tradenames:1
Ingredients:1
NDAs:1
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Shire Orphan TherapFIRAZYRicatibant acetateINJECTABLE;SUBCUTANEOUS022150-001Aug 25, 2011RXYesYes► Subscribe► SubscribeYY► Subscribe
Shire Orphan TherapFIRAZYRicatibant acetateINJECTABLE;SUBCUTANEOUS022150-001Aug 25, 2011RXYesYes► Subscribe► Subscribe► Subscribe
Shire Orphan TherapFIRAZYRicatibant acetateINJECTABLE;SUBCUTANEOUS022150-001Aug 25, 2011RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for SHIRE ORPHAN THERAP drugs

Drugname Dosage Strength Tradename Submissiondate
icatibantInjection10 mg/mLFIRAZYR8/25/2015

International Patent Family for Shire Orphan Therap Drugs

Country Document Number Estimated Expiration
China1049505► Subscribe
Czechoslovakia9003979► Subscribe
New Zealand230244► Subscribe
Hungary904989► Subscribe
Czechoslovakia9101165► Subscribe
Hungary208324► Subscribe
China1034416► Subscribe
HungaryT60286► Subscribe
Lithuania3375► Subscribe
Austria114320► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Shire Orphan Therap Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
499Luxembourg► Subscribe91499, EXPIRES: 20141121
C0002France► SubscribePRODUCT NAME: ICATIBANT, EVENTUELLEMENT SOUS FORME DE SEL PHYSIOLOGIQUEMENT ACCEPTABLE, NOTAMMENT L?ACETATE D?ICATIBANT; REGISTRATION NO/DATE IN FRANCE: EU/1/08/461/001 DU 20080711; REGISTRATION NO/DATE AT EEC: EU/1/08/461/001 DU 20080711
00359Netherlands► SubscribePRODUCT NAME: ICATIBANT, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, BIJ VOORKEUR ICATIBANTACETAAT; REGISTRATION NO/DATE: EU/1/048/461/001 20080711
/2008Austria► SubscribePRODUCT NAME: ICATIBANT, WAHLWEISE IN FORM EINES PHYSIOLOGISCH ANNEHMBAREN SALZES, EINSCHLIESSLICH ICATIBANT-ACETAT; REGISTRATION NO/DATE: EU/1/08/461/001 20080711
0359Netherlands► Subscribe300359, 20091121, EXPIRES: 20141120
C/GB09/002United Kingdom► SubscribePRODUCT NAME: ICATIBANT, OR A PHYSIOLOGICALLY TOLERABLE SALT THEREOF, INCLUDING ICATIBANT ACETATE; REGISTERED: UK EU/1/08/461/001 20080711
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Cipla
Farmers Insurance
Baxter
Merck
Healthtrust
Queensland Health
Mallinckrodt
Federal Trade Commission
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot